Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-032317

President sold 50,000 shares at an average $70.20 ($3,510,020)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2020-05-22 Sale −13,384 $70.01 $937,014 784,623 D: show line 1 in the form
Novak Rodger President 2020-05-26 Sale −36,616 $70.27 $2,573,006 748,007 D: show line 2 in the form
Open-market sales · 50,000 sh · avg $70.20 · $3,510,020
Loading xslF345X03/doc4.xml…